. | All TAVI . | TF-AVI . | TA-AVI . |
---|---|---|---|
n | 44 | 32 | 12 |
Age (years)a | 78 ± 6 | 79 ± 5 | 74 ± 8 |
Male sexb | 24 (55) | 17 (53) | 8 (67) |
NYHA classc | III (III; III) | III (III; III) | III (III; III) |
Log EuroSCORE (%)a | 28 ± 15 | 29 ± 17 | 25 ± 10 |
LV-EF (%)a | 48 ± 17 | 46 ± 16 | 55 ± 18 |
Valve area (cm2)a | 0.6 ± 0.2 | 0.7 ± 0.2 | 0.6 ± 0.2 |
History of atrial fibrillationb | 3 (7) | 3 (9) | 0 (0) |
Coronary artery diseaseb | 27 (61) | 19 (59) | 8 (67) |
History of strokeb | 1 (2) | 1 (3) | 0 (0) |
ICA stenosis >50%b | 7 (16) | 6 (19) | 1 (8) |
. | All TAVI . | TF-AVI . | TA-AVI . |
---|---|---|---|
n | 44 | 32 | 12 |
Age (years)a | 78 ± 6 | 79 ± 5 | 74 ± 8 |
Male sexb | 24 (55) | 17 (53) | 8 (67) |
NYHA classc | III (III; III) | III (III; III) | III (III; III) |
Log EuroSCORE (%)a | 28 ± 15 | 29 ± 17 | 25 ± 10 |
LV-EF (%)a | 48 ± 17 | 46 ± 16 | 55 ± 18 |
Valve area (cm2)a | 0.6 ± 0.2 | 0.7 ± 0.2 | 0.6 ± 0.2 |
History of atrial fibrillationb | 3 (7) | 3 (9) | 0 (0) |
Coronary artery diseaseb | 27 (61) | 19 (59) | 8 (67) |
History of strokeb | 1 (2) | 1 (3) | 0 (0) |
ICA stenosis >50%b | 7 (16) | 6 (19) | 1 (8) |
NYHA: New York Health Association class; Log EuroSCORE: European System for Cardiac Operative Risk Evaluation Score; LV-EF: left ventricular ejection fraction; ICA: internal carotid artery; TAVI: transcatheter aortic valve implantation; TF-AVI: transfemoral aortic valve implantation; TA-AVI: transapical aortic valve implantation. aValues are the mean ± SD.
bValues are n (%).
cValues are the median (25th; 75th percentiles).
. | All TAVI . | TF-AVI . | TA-AVI . |
---|---|---|---|
n | 44 | 32 | 12 |
Age (years)a | 78 ± 6 | 79 ± 5 | 74 ± 8 |
Male sexb | 24 (55) | 17 (53) | 8 (67) |
NYHA classc | III (III; III) | III (III; III) | III (III; III) |
Log EuroSCORE (%)a | 28 ± 15 | 29 ± 17 | 25 ± 10 |
LV-EF (%)a | 48 ± 17 | 46 ± 16 | 55 ± 18 |
Valve area (cm2)a | 0.6 ± 0.2 | 0.7 ± 0.2 | 0.6 ± 0.2 |
History of atrial fibrillationb | 3 (7) | 3 (9) | 0 (0) |
Coronary artery diseaseb | 27 (61) | 19 (59) | 8 (67) |
History of strokeb | 1 (2) | 1 (3) | 0 (0) |
ICA stenosis >50%b | 7 (16) | 6 (19) | 1 (8) |
. | All TAVI . | TF-AVI . | TA-AVI . |
---|---|---|---|
n | 44 | 32 | 12 |
Age (years)a | 78 ± 6 | 79 ± 5 | 74 ± 8 |
Male sexb | 24 (55) | 17 (53) | 8 (67) |
NYHA classc | III (III; III) | III (III; III) | III (III; III) |
Log EuroSCORE (%)a | 28 ± 15 | 29 ± 17 | 25 ± 10 |
LV-EF (%)a | 48 ± 17 | 46 ± 16 | 55 ± 18 |
Valve area (cm2)a | 0.6 ± 0.2 | 0.7 ± 0.2 | 0.6 ± 0.2 |
History of atrial fibrillationb | 3 (7) | 3 (9) | 0 (0) |
Coronary artery diseaseb | 27 (61) | 19 (59) | 8 (67) |
History of strokeb | 1 (2) | 1 (3) | 0 (0) |
ICA stenosis >50%b | 7 (16) | 6 (19) | 1 (8) |
NYHA: New York Health Association class; Log EuroSCORE: European System for Cardiac Operative Risk Evaluation Score; LV-EF: left ventricular ejection fraction; ICA: internal carotid artery; TAVI: transcatheter aortic valve implantation; TF-AVI: transfemoral aortic valve implantation; TA-AVI: transapical aortic valve implantation. aValues are the mean ± SD.
bValues are n (%).
cValues are the median (25th; 75th percentiles).
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.